Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al.
Finley
David S
DS
David Geffen School of Medicine at UCLA, 650 Charles Young Drive, Box 951738 Los Angeles, CA 90095-1738, USA.
Pouliot
Frederic
F
Pantuck
Allan
A